Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey

Japanese Journal of Infectious Diseases

Volumn 59, Issue 2, 2006, Pages 117-119

  Ercis, Serpil ^a   Erdem, Birsel ^b   Hasçelik, Gülşen ^a   Gür, Deniz ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Ihsan Do ramac Children's Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POPULATION DISTRIBUTION; SALMONELLA; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA; SENSITIVITY AND SPECIFICITY; SEROTYPING; TREATMENT OUTCOME; TURKEY;

EID: 33646205694     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Miller, S. I., Hohmann, E. L. and Pegues, D. A. (1995): Salmonella. p. 2013-2033. In G. L. Mandell, J. E. Bennett and R. Dolin (ed.), Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. Churchill Livingstone Inc., New York.
2. Chiu, C. H., Wu, T. L., Su, L. H., Chu, C., Chia, J. H., Kuo, A. J., Chien, M. S. and Lin, T. Y. (2002): The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N. Engl. J. Med., 346, 413-419.
3. Lontie, M., Verhaegen, J., Chasseur-Libotte, M. L. and Verbist, L. (1994): Salmonella typhimurium serovar Copenhagen highly resistant to fluoroquinolones. J. Antimicrob. Chemother., 34, 845-846.
4. Mehta, G., Randhawa, V S. and Mohapatra, N. P. (2001): Intermediate susceptibility to ciprofloxacin in Salmonella typhi strains in India. Eur. J. Clin. Microbiol. Infect. Dis., 20, 760-761.
5. Marimón José, M., Gomáriz, M., Zigorraga, C., Cilla, G. and Pérez-Trallero, E. (2004): Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003. Antimicrob. Agents Chemother., 48, 3789-3793.
6. Lostec, Z. L., Fegueux, S., Jouve, P., Cheron, M., Mornet, P. and Boisivon, A. (1997): Reduced susceptibility to quinolones in Salmonella Typhi acquired in Europe: a clinical failure of treatment. Clin. Microbiol. Infect., 3, 576-577.
7. Asna, S. M. Z., Haq, J. A. and Rahman, M. (2003): Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh. Jpn. J. Infect. Dis., 56, 32-33.
8. Hakanen, A., Kotilainen, P., Jalava, J., Siitonen, A. and Huovinen, P. (1999): Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. J. Clin. Microbiol., 37, 3572-3577.
9. Kapil, A. R. and Das, B. (2002): Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella Typhi. Indian J. Med. Res., 115, 49-54.
10. Clinical and Laboratory Standards Institute (2005): Performance standards for antimicrobial susceptibility testing. 15th Informational Supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa, USA.
11. Budak, F., Gür, D., Dündar, V. and Gülay, Z. (2003): Rate of antimicrobial resistance and extended spectrum beta-lactamase production in Salmonella species. Turkish J. Infect., 17, 189-195.
12. Willke, A., Arman, D., Çokça, F., Sumerkan, B., Soyletir, G., Bakir, M., Sirmatel, F., Leblebicioglu, H. and Kijlijc, S. (1999): Resistance of Salmonella and Shigella in Turkey. Clin. Microbiol. Infect., 5, 588-590.
13. Threlfall, E. J. and Ward, L. R. (2001): Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Emerg. Infect. Dis., 7, 448-450.
14. Hakanen, A., Kotilainen, P., Huovinen, P., Helenius, H. and Siitonen, A. (2001): Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg. Infect. Dis., 7, 996-1003.
15. Albayrak, F., Çokça, F., Erdem, B. and Aysev, A. D. (2004): Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility. Int. J. Antimicrob. Agents, 23, 332-336.